Crystallographic rationalization of the reactivity and spectroscopic properties of (2R)‐S‐(2,5‐dihydroxyphenyl)cysteine

At 150 K, the title compound, C₉H₁₁NO₄S, crystallizes in the orthorhombic form as a zwitterion and has a low gauche conformation [χ = −46.23 (16)°] for an acyclic cysteine derivative. A difference in bond length is observed for the alkyl C—S bond [1.8299 (15) Å] and the aryl C—S bond [1.7760 (15) Å]. The –NH₃⁺ group is involved in four hydrogen bonds, two of which are intermolecular and two intramolecular. The compound forms an infinite three‐dimensional network constructed from four intermolecular hydrogen bonds. Characterization data (¹³C NMR, IR and optical rotation) are reported to supplement the incomplete data disclosed previously in the literature.     

Bis (2,4,6,8-cyclononatetraen-1-yl)methane

Bis (2,4,6,8-cyclononatetraen-1-yl)methanes Bis (2,4,6,8-cyclononatetraen-1-yl)methanes ( 2a–c ) have been prepared by reaction of all-cis-cyclononatetraenide with 1,1-dichlorodimethyl ether as well as with carbenium ion precursors 9b and 9c . The title compounds 2 are attractive precursors of highly delocalised nonafulvenes of type 3 ; however, elimination experiments 2→3 failed so far.     

Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction

Cannabinoids comprise different classes of compounds, which aroused interest in recent years because of their several pharmacological properties. Such properties include analgesic activity, bodyweight reduction, the antiemetic effect, the reduction of intraocular pressure and many others, which appear correlated to the affinity of cannabinoids towards CB₁ and/or CB₂ receptors. Within the search aiming to identify novel chemical scaffolds for cannabinoid receptor interaction, the CB₁ antagonist/inverse agonist pyrazole-based derivative rimonabant has been modified, giving rise to several tricyclic pyrazole-based compounds, most of which endowed of high affinity and selectivity for CB₁ or CB₂ receptors. The aim of this review is to present the synthesis and summarize the SAR study of such tricyclic pyrazole-based compounds, evidencing, for some derivatives, their potential in the treatment of neuropathic pain, obesity or in the management of glaucoma.     

Untersuchungen an Natriumtrifluormethylsulfonat – Kristallstruktur und Phasenumwandlung des Monohydrats und Natriumionenleitfähigkeit des wasserfreien Salzes

Studies on Sodium Trifluormethanesulfonate – Crystal Structure and Phase Transition of Sodium Trifluormethanesulfonate Monohydrate and Sodium Ion Conductivity of Anhydrous Sodium Trifluormethanesulfonate According to the results of temperature dependent powder diffractometry (Guinier-Simon-technique) sodium trifluormethanesulfonate monohydrate is dimorphous. The phase transition occurs at ?35°C. The room-temperature modification crystallizes monoclinic in space group P2₁/c with the lattice parameters a = 941.6(5) pm, b = 654.3(2) pm, c = 1062.4(5) pm and β = 107.73(2)°. The crystal structure consists of double layers of trifluormethanesulfonate anions, the lipophilic CF₃-groups pointing at each other. Sodium is coordinated by four oxygen atoms from four different anions and by two molecules of crystal water. The resulting polyhedron may be addressed as a distorted octahedron. The low-temperature modification crystallizes orthorhombic in space group Pnma with the lattice parameters a = 645.31(9) pm, b = 538.03(9) pm, c = 1745.3(3) pm. The loss of crystal water occurs at 136°C. Anhydrous sodium trifluormethanesulfonate shows a phase transition at 252°C. The high-temperature modification is a good sodium ionic conductor (σ = 4.1 · 10^?1 Ω^?1 cm^?1 at 250°C).     

In Vitro Effects of Sulforaphane on Interferon-Driven Inflammation and Exploratory Evaluation in Two Healthy Volunteers

Interferonopathies are rare genetic conditions defined by systemic inflammatory episodes caused by innate immune system activation in the absence of pathogens. Currently, no targeted drugs are authorized for clinical use in these diseases. In this work, we studied the contribution of sulforaphane (SFN), a cruciferous-derived bioactive molecule, in the modulation of interferon-driven inflammation in an immortalized human hepatocytes (IHH) line and in two healthy volunteers, focusing on STING, a key-component player in interferon pathway, interferon signature modulation, and GSTM1 expression and genotype, which contributes to SFN metabolism and excretion. In vitro, SFN exposure reduced STING expression as well as interferon signature in the presence of the pro-inflammatory stimulus cGAMP (cGAMP 3 h vs. SFN+cGAMP 3 h p value < 0.0001; cGAMP 6 h vs. SFN+cGAMP 6 h p < 0.001, one way ANOVA), restoring STING expression to the level of unstimulated cells. In preliminary experiments on healthy volunteers, no appreciable variations in interferon signature were identified after SFN assumption, while only in one of them, presenting the GSTM1 wild type genotype related to reduced SFN excretion, could a downregulation of STING be recorded. This study confirmed that SFN inhibits STING-mediated inflammation and interferon-stimulated genes expression in vitro. However, only a trend towards the downregulation of STING could be reproduced in vivo. Results obtained have to be confirmed in a larger group of healthy individuals and in patients with type I interferonopathies to define if the assumption of SFN could be useful as supportive therapy.     

A Universal Cassette-Based System for the Dissolution of Solid Targets

Cyclotron-based radionuclides production by using solid targets has become important in the last years due to the growing demand of radiometals, e.g., ⁶⁸Ga, ⁸⁹Zr, ^43/47Sc, and ^52/54Mn. This shifted the focus on solid target management, where the first fundamental step of the radiochemical processing is the target dissolution. Currently, this step is generally performed with commercial or home-made modules separated from the following purification/radiolabelling modules. The aim of this work is the realization of a flexible solid target dissolution system to be easily installed on commercial cassette-based synthesis modules. This would offer a complete target processing and radiopharmaceutical synthesis performable in a single module continuously. The presented solid target dissolution system concept relies on an open-bottomed vial positioned upon a target coin. In particular, the idea is to use the movement mechanism of a syringe pump to position the vial up and down on the target, and to exploit the heater/cooler reactor of the module as a target holder. All the steps can be remotely controlled and are incorporated in the cassette manifold together with the purification and radiolabelling steps. The performance of the device was tested by processing three different irradiated targets under different dissolution conditions.     

Reactions of Organic Azides with Half‐sandwich Complexes of Iridium: Preparation of Mono‐ and Bis(imine) Derivatives

Imine complexes [IrCl(η⁵‐C₅Me₅){κ¹‐NH=C(H)Ar}{P(OR)₃}]BPh₄ ( 1 , 2 ) (Ar = C₆H₅, 4‐CH₃C₆H₄; R = Me, Et) were prepared by allowing chloro complexes [IrCl₂(η⁵‐C₅Me₅){P(OR)₃}] to react with benzyl azides ArCH₂N₃. Bis(imine) complexes [Ir(η⁵‐C₅Me₅){κ¹‐NH=C(H)Ar}₂{P(OR)₃}](BPh₄)₂ ( 3 , 4 ) were also prepared by reacting [IrCl₂(η⁵‐C₅Me₅){P(OR)₃}] first with AgOTf and then with benzyl azide. Depending on the experimental conditions, treatment of the dinuclear complex [IrCl₂(η⁵‐C₅Me₅)]₂ with benzyl azide yielded mono‐ [IrCl₂(η⁵‐C₅Me₅){κ¹‐NH=C(H)Ar}] ( 5 ) and bis‐[IrCl(η⁵‐C₅Me₅){κ¹‐NH=C(H)Ar}₂]BPh₄ ( 6 ) imine derivatives. In contrast, treatment of chloro complexes [IrCl₂(η⁵‐C₅Me₅){P(OR)₃}] with phenyl azide C₆H₅N₃ gave amine derivatives [IrCl(η⁵‐C₅Me₅)(C₆H₅NH₂){P(OR)₃}]BPh₄ ( 7 , 8 ). The complexes were characterized spectroscopically (IR, NMR) and by X‐ray crystal structure determination of [IrCl(η⁵‐C₅Me₅){κ¹‐NH=C(H)C₆H₄‐4‐CH₃}{P(OEt)₃}]BPh₄ ( 2b ).     

Screening of Three Transition Metal‐Mediated Reactions Compatible with DNA‐Encoded Chemical Libraries

The construction of DNA‐encoded chemical libraries (DECLs) crucially relies on the availability of chemical reactions, which are DNA‐compatible and which exhibit high conversion rates for a large number of diverse substrates. In this work, we present our optimization and validation procedures for three copper and palladium‐catalyzed reactions (Suzuki cross‐coupling, Sonogashira cross‐coupling, and copper(I)‐catalyzed alkyne‐azide cycloaddition (CuAAC)), which have been successfully used by our group for the construction of large encoded libraries.